1. United States. Depression Guideline Panel., United States. Agency for Health Care Policy and Research. Depression in Primary Care. Washington, D.C.: US Deptartment of Health and Human Services; 1993.
2. Rush AJ, Trivedi MH, Stewart JW, Nierenberg AA, Fava M, Kurian BT, et al. Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. Am J Psychiatry 2011;168:689–701. PMID:
21536692.
3. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR
*D report. Am J Psychiatry 2006;163:1905–1917. PMID:
17074942.
4. Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association. Am J Psychiatry 2000;157(1 Suppl):1–39.
5. Thase ME. Antidepressant combinations: widely used, but far from empirically validated. Can J Psychiatry 2011;56:317–323. PMID:
21756445.
6. Blier P, Ward HE, Tremblay P, Laberge L, Hebert C, Bergeron R. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study. Am J Psychiatry 2010;167:281–288. PMID:
20008946.
7. Nemeroff CB, Schatzberg AF, Goldstein DJ, Detke MJ, Mallinckrodt C, Lu Y, et al. Duloxetine for the treatment of major depressive disorder. Psychopharmacol Bull 2002;36:106–132. PMID:
12858150.
8. Detke MJ, Lu Y, Goldstein DJ, Hayes JR, Demitrack MA. Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial. J Clin Psychiatry 2002;63:308–315. PMID:
12000204.
9. Detke MJ, Lu Y, Goldstein DJ, McNamara RK, Demitrack MA. Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression. J Psychiatr Res 2002;36:383–390. PMID:
12393307.
10. Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. Eur Neuropsychopharmacol 2004;14:457–470. PMID:
15589385.
11. Goldstein DJ, Mallinckrodt C, Lu Y, Demitrack MA. Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial. J Clin Psychiatry 2002;63:225–231. PMID:
11926722.
12. Goldstein DJ, Lu Y, Detke MJ, Wiltse C, Mallinckrodt C, Demitrack MA. Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine. J Clin Psychopharmacol 2004;24:389–399. PMID:
15232330.
13. Perahia DG, Gilaberte I, Wang F, Wiltse CG, Huckins SA, Clemens JW, et al. Duloxetine in the prevention of relapse of major depressive disorder: double-blind placebo-controlled study. Br J Psychiatry 2006;188:346–353. PMID:
16582061.
14. Gartlehner G, Thaler K, Hansen RA, Gaynes BN. The general and comparative efficacy and safety of duloxetine in major depressive disorder: a systematic review and meta-analysis. Drug Saf 2009;32:1159–1173. PMID:
19916583.
15. Hudson JI, Wohlreich MM, Kajdasz DK, Mallinckrodt CH, Watkin JG, Martynov OV. Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials. Hum Psychopharmacol 2005;20:327–341. PMID:
15912562.
16. American Psychiatric Association. Diagnostic Criteria from DSM-IV-TR. Washington, D.C.: American Psychiatric Association; 2000.
17. Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont) 2007;4:28–37. PMID:
20526405.
18. Rocha FL, Fuzikawa C, Riera R, Hara C. Combination of antidepressants in the treatment of major depressive disorder: a systematic review and meta-analysis. J Clin Psychopharmacol 2012;32:278–281. PMID:
22367652.
19. Rush AJ. Combining antidepressant medications: a good idea? Am J Psychiatry 2010;167:241–243. PMID:
20194484.
20. Thase ME. Combined antidepressant strategies are not more effective than vigorous escitalopram monotherapy: results of the CO-MED study. Curr Psychiatry Rep 2011;13:434–436. PMID:
21956831.
21. Fornaro M, Martino M, Mattei C, Prestia D, Vinciguerra V, De Berardis D, et al. Duloxetine-bupropion combination for treatment-resistant atypical depression: a double-blind, randomized, placebo-controlled trial. Eur Neuropsychopharmacol 2014;24:1269–1278. PMID:
24842649.